Complexities of Type I Interferon Biology: Lessons from LCMV.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
20 02 2019
Historique:
received: 22 01 2019
revised: 17 02 2019
accepted: 18 02 2019
entrez: 23 2 2019
pubmed: 23 2 2019
medline: 19 9 2019
Statut: epublish

Résumé

Over the past decades, infection of mice with lymphocytic choriomeningitis virus (LCMV) has provided an invaluable insight into our understanding of immune responses to viruses. In particular, this model has clarified the central roles that type I interferons play in initiating and regulating host responses. The use of different strains of LCMV and routes of infection has allowed us to understand how type I interferons are critical in controlling virus replication and fostering effective antiviral immunity, but also how they promote virus persistence and functional exhaustion of the immune response. Accordingly, these discoveries have formed the foundation for the development of novel treatments for acute and chronic viral infections and even extend into the management of malignant tumors. Here we review the fundamental insights into type I interferon biology gained using LCMV as a model and how the diversity of LCMV strains, dose, and route of administration have been used to dissect the molecular mechanisms underpinning acute versus persistent infection. We also identify gaps in the knowledge regarding LCMV regulation of antiviral immunity. Due to its unique properties, LCMV will continue to remain a vital part of the immunologists' toolbox.

Identifiants

pubmed: 30791575
pii: v11020172
doi: 10.3390/v11020172
pmc: PMC6409748
pii:
doi:

Substances chimiques

Interferon Type I 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

FEBS Lett. 1998 Dec 11;441(1):106-10
pubmed: 9877175
Eur J Immunol. 2005 Mar;35(3):822-30
pubmed: 15724245
J Virol. 1993 Jan;67(1):332-9
pubmed: 8093219
J Virol. 2005 Jun;79(12):7514-27
pubmed: 15919906
PLoS Pathog. 2013;9(7):e1003478
pubmed: 23874199
Cytokine Growth Factor Rev. 2016 Jun;29:71-81
pubmed: 27053489
Nature. 2011 Nov 20;481(7381):394-8
pubmed: 22101430
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Proc Natl Acad Sci U S A. 1990 Nov;87(21):8555-9
pubmed: 2236065
Immunol Rev. 2012 Nov;250(1):317-34
pubmed: 23046138
J Gen Virol. 1977 Oct;37(1):85-92
pubmed: 335024
Trends Immunol. 2017 Aug;38(8):542-557
pubmed: 28579323
J Neuroimmunol. 2008 Feb;194(1-2):70-82
pubmed: 18295350
mBio. 2016 Apr 12;7(2):e00437-16
pubmed: 27073094
J Immunol. 2006 Mar 15;176(6):3315-9
pubmed: 16517698
PLoS Biol. 2009 Apr 7;7(4):e1000080
pubmed: 19355789
Curr Top Microbiol Immunol. 2002;263:7-27
pubmed: 11987821
J Virol. 2004 Aug;78(15):8219-28
pubmed: 15254193
J Virol. 2012 Oct;86(20):11254-65
pubmed: 22875973
J Virol. 1994 Dec;68(12):8056-63
pubmed: 7966595
Science. 1935 Mar 22;81(2099):298-9
pubmed: 17771201
J Neuroinflammation. 2016 Oct 24;13(1):277
pubmed: 27776548
Nat Rev Cancer. 2016 Mar;16(3):131-44
pubmed: 26911188
Science. 2013 Apr 12;340(6129):207-11
pubmed: 23580529
Immunity. 2005 Feb;22(2):247-57
pubmed: 15723812
Immunity. 2014 Jun 19;40(6):949-60
pubmed: 24909887
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3012-7
pubmed: 22315415
J Gen Virol. 1983 Aug;64 (Pt 8):1689-98
pubmed: 6875516
J Exp Med. 2007 Oct 1;204(10):2383-96
pubmed: 17846149
J Virol. 2012 Jun;86(12):6932-46
pubmed: 22496215
J Immunol. 2012 May 1;188(9):4432-40
pubmed: 22447976
J Immunol. 2006 Apr 15;176(8):4525-9
pubmed: 16585541
J Exp Med. 1982 Jul 1;156(1):79-89
pubmed: 6979608
Nat Rev Immunol. 2008 Aug;8(8):594-606
pubmed: 18641647
Scand J Immunol. 1994 Oct;40(4):373-82
pubmed: 7939408
Virology. 2004 Aug 1;325(2):432-45
pubmed: 15246281
Immunol Rev. 2004 Dec;202:8-32
pubmed: 15546383
J Virol. 2017 Oct 27;91(22):
pubmed: 28878077
J Immunol. 1985 Jan;134(1):608-15
pubmed: 3871115
PLoS Pathog. 2015 Jan 08;11(1):e1004588
pubmed: 25569216
Science. 2013 Apr 12;340(6129):202-7
pubmed: 23580528
Nat Med. 2007 Nov;13(11):1316-23
pubmed: 17982463
Science. 1998 Dec 11;282(5396):2079-81
pubmed: 9851928
Genes Dev. 1990 Oct;4(10):1753-65
pubmed: 2249773
J Exp Med. 1998 Dec 21;188(12):2205-13
pubmed: 9858507
FEBS Lett. 1998 Mar 20;425(1):112-6
pubmed: 9541017
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21641-6
pubmed: 21098292
J Immunol. 2006 Sep 1;177(5):3266-72
pubmed: 16920967
J Exp Med. 1973 Nov 1;138(5):1266-9
pubmed: 4542807
J Exp Med. 2014 May 5;211(5):961-74
pubmed: 24711580
J Virol. 2014 Jul;88(13):7578-88
pubmed: 24760883
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7814-E7823
pubmed: 30061383
Curr Opin Virol. 2011 Sep;1(3):160-6
pubmed: 21909344
Virology. 2013 May 10;439(2):152-62
pubmed: 23490048
Immunity. 2010 Mar 26;32(3):305-15
pubmed: 20346772
Genes Cells. 1996 Jan;1(1):115-24
pubmed: 9078371
Eur J Immunol. 1986 Apr;16(4):387-93
pubmed: 3084281
J Virol. 2010 Sep;84(18):9452-62
pubmed: 20592086
Eur J Immunol. 1986 Aug;16(8):913-7
pubmed: 3488911
J Virol. 1996 Dec;70(12):8988-92
pubmed: 8971029
J Virol. 2001 Sep;75(18):8407-23
pubmed: 11507186
Viruses. 2010 Nov;2(11):2443-80
pubmed: 21994626
Trends Immunol. 2015 Apr;36(4):265-76
pubmed: 25797516
J Virol. 2001 Jan;75(1):448-57
pubmed: 11119613
Cell Host Microbe. 2015 May 13;17(5):653-61
pubmed: 25974304
J Virol. 1984 Sep;51(3):682-6
pubmed: 6332201
Nature. 1969 Jun 14;222(5198):1045-7
pubmed: 4977740
Front Immunol. 2016 Dec 05;7:564
pubmed: 27994594
J Clin Invest. 2004 Mar;113(5):737-45
pubmed: 14991072
Front Immunol. 2017 Jan 26;8:29
pubmed: 28184222
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3829-33
pubmed: 7537377
Mol Cell Biol. 1991 Aug;11(8):4189-95
pubmed: 1906577
Science. 1935 May 3;81(2105):439-40
pubmed: 17750170
Immunol Rev. 1993 Jun;133:199-223
pubmed: 8225368
J Virol. 2008 Feb;82(3):1505-17
pubmed: 18045945
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21182-7
pubmed: 22160724
Sci Immunol. 2016 Oct;1(4):
pubmed: 27812556
J Immunol. 2008 Sep 15;181(6):3804-10
pubmed: 18768833
Cell Commun Signal. 2017 Jan 5;15(1):1
pubmed: 28073373
Ann Hematol. 2015 Apr;94 Suppl 2:S195-207
pubmed: 25814086
Nat Rev Immunol. 2006 Mar;6(3):231-43
pubmed: 16498452
EMBO J. 1998 Nov 16;17(22):6660-9
pubmed: 9822609
Nat Immunol. 2013 Apr;14(4):346-55
pubmed: 23416614
Cell Host Microbe. 2012 Jun 14;11(6):631-42
pubmed: 22704623
Nat Rev Immunol. 2015 Feb;15(2):87-103
pubmed: 25614319
Nat Immunol. 2004 Oct;5(10):1061-8
pubmed: 15361868
Emerg Infect Dis. 2010 Jul;16(7):1093-100
pubmed: 20587180
J Virol. 1994 Mar;68(3):1951-5
pubmed: 8107255
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Blood. 2009 Jan 29;113(5):1045-52
pubmed: 18971424
Front Biosci. 2008 May 01;13:4529-43
pubmed: 18508527
PLoS One. 2012;7(7):e40865
pubmed: 22815848
J Virol. 2006 Sep;80(18):9192-9
pubmed: 16940530
Sci Transl Med. 2015 Sep 30;7(307):307ra154
pubmed: 26424569
J Virol. 1995 Aug;69(8):4792-6
pubmed: 7609046
J Immunol. 2003 Nov 1;171(9):4733-41
pubmed: 14568949
J Biol Chem. 2003 May 2;278(18):15495-504
pubmed: 12604599
Science. 1994 Jun 24;264(5167):1918-21
pubmed: 8009221
J Exp Med. 2000 Nov 6;192(9):1249-60
pubmed: 11067874
J Immunol. 1987 Apr 1;138(7):2278-81
pubmed: 2435794
J Virol. 2008 Jan;82(1):196-206
pubmed: 17942529
J Virol. 1988 Jun;62(6):2102-6
pubmed: 2966865
Cytokine Growth Factor Rev. 2014 Oct;25(5):621-8
pubmed: 24894317
J Neuroimmunol. 1998 Jun 15;86(2):202-12
pubmed: 9663567
J Immunol. 1994 Jul 1;153(1):220-31
pubmed: 8207238
J Exp Med. 1984 Aug 1;160(2):521-40
pubmed: 6332167
Cytokine Growth Factor Rev. 2016 Jun;29:35-43
pubmed: 26987614
J Immunol. 2013 Jan 15;190(2):641-9
pubmed: 23241878
Vet Microbiol. 2017 May;203:234-244
pubmed: 28619150
J Immunol. 1961 Apr;86:392-400
pubmed: 13716107
Curr Opin Immunol. 2015 Jun;34:91-8
pubmed: 25771184
Exp Anim. 2017 Aug 5;66(3):199-208
pubmed: 28260717
Viral Immunol. 2011 Oct;24(5):375-85
pubmed: 21929334
J Gen Virol. 1983 Aug;64 (Pt 8):1827-30
pubmed: 6192206
Virology. 2004 May 1;322(2):231-8
pubmed: 15110521
J Clin Oncol. 2011 Apr 20;29(12):1634-42
pubmed: 21422420
Mol Cell Biol. 1993 Jan;13(1):196-206
pubmed: 8417326
Genes Dev. 1989 Sep;3(9):1362-71
pubmed: 2606351
Genes Cells. 1996 Nov;1(11):995-1005
pubmed: 9077462
Immunology. 2017 Oct;152(2):328-343
pubmed: 28582800
J Exp Med. 1999 Apr 19;189(8):1315-28
pubmed: 10209048
J Exp Med. 2005 Sep 5;202(5):637-50
pubmed: 16129706
J Virol. 2012 Jul;86(13):7384-92
pubmed: 22514347

Auteurs

Tamara Suprunenko (T)

School of Life and Environmental Sciences, the Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, and the Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia. tsup5163@uni.sydney.edu.au.

Markus J Hofer (MJ)

School of Life and Environmental Sciences, the Marie Bashir Institute for Infectious Diseases and Biosecurity, Charles Perkins Centre, and the Bosch Institute, The University of Sydney, Sydney, NSW 2006, Australia. markus.hofer@sydney.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH